Paul Dorian

1.3k total citations
31 papers, 707 citations indexed

About

Paul Dorian is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Paul Dorian has authored 31 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Paul Dorian's work include Cardiac electrophysiology and arrhythmias (17 papers), Cardiac Arrhythmias and Treatments (13 papers) and Atrial Fibrillation Management and Outcomes (9 papers). Paul Dorian is often cited by papers focused on Cardiac electrophysiology and arrhythmias (17 papers), Cardiac Arrhythmias and Treatments (13 papers) and Atrial Fibrillation Management and Outcomes (9 papers). Paul Dorian collaborates with scholars based in Canada, United Kingdom and United States. Paul Dorian's co-authors include David Newman, P Coumel, Gerald V. Naccarelli, Stefan H. Hohnloser, Dan Cass, K. Ahmad, Xiangqian Qi, Edward M. Sellers, David Newman and Andreas Kuznik and has published in prestigious journals such as Annals of Internal Medicine, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Paul Dorian

30 papers receiving 659 citations

Peers

Paul Dorian

CCM

SURGE

Marten E. van den Berg Netherlands

A.V. Zezulka United Kingdom

P Sassano France

Sofie Brouwers Belgium

Fanny Vaillant France

Heinrich Holzgreve Germany

G. Frangin France

Brian F. McBride United States

L. Michael Prisant United States

AJ Camm United Kingdom

Marten E. van den Berg Netherlands

Paul Dorian

392 ×0.7

CCM

82 ×0.7

7 ×0.1

50 ×1.1

SURGE

69 ×1.5

Citations per year, relative to Paul Dorian Paul Dorian (= 1×) peers Marten E. van den Berg

Countries citing papers authored by Paul Dorian

Since Specialization

Citations

This map shows the geographic impact of Paul Dorian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Dorian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Dorian more than expected).

Fields of papers citing papers by Paul Dorian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Dorian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Dorian. The network helps show where Paul Dorian may publish in the future.

Co-authorship network of co-authors of Paul Dorian

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Dorian. A scholar is included among the top collaborators of Paul Dorian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Dorian. Paul Dorian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abdel‐Qadir, Husam, Jiming Fang, Peter C. Austin, et al.. (2025). Risk for Stroke After Newly Diagnosed Atrial Fibrillation During Hospitalization for Other Primary Diagnoses. Annals of Internal Medicine. 178(6). 765–774. 1 indexed citations

Nakajima, Erika, Andrew C.T. Ha, Feng Qiu, et al.. (2025). East Asian immigration and direct oral anticoagulant dosing for atrial fibrillation: A population-based cohort study. Heart Rhythm. 22(10). e849–e857. 1 indexed citations

Pósán, Emőke, Gregory Golovchiner, Paul Dorian, & Arnold Pintér. (2009). Three-dimensional bipolar voltage map demonstrating electrical activity of a single muscle bundle along the cavotricuspid isthmus. Canadian Journal of Cardiology. 25(3). e92–e92. 1 indexed citations

Jenkins, David J.A., Andrea R. Josse, Joseph Beyene, et al.. (2008). Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis. Canadian Medical Association Journal. 178(2). 157–164. 47 indexed citations

Ahmad, K. & Paul Dorian. (2007). Drug-induced QT prolongation and proarrhythmia: an inevitable link?. EP Europace. 9(Supplement 4). iv16–iv22. 29 indexed citations

Dorian, Paul, et al.. (2006). Using Transthoracic Two‐Dimensional Echocardiography to Guide the Placement of Coronary Sinus Catheters: A Randomized Study. Echocardiography. 23(2). 93–96. 2 indexed citations

Atkins, Dianne L., Paul Dorian, Edgar R. Gonzalez, et al.. (2001). Treatment of tachyarrhythmias. Annals of Emergency Medicine. 37(4). S91–S109. 20 indexed citations

Qi, Xiangqian, David Newman, & Paul Dorian. (1999). Azimilide Decreases Defibrillation Voltage Requirements and Increases Spatial Organization During Ventricular Fibrillation. Journal of Interventional Cardiac Electrophysiology. 3(1). 61–67. 27 indexed citations

Newman, David, et al.. (1998). A Double-Blind Placebo-Controlled Evaluation of the Human Electrophysiologic Effects of Zatebradine, a Sinus Node Inhibitor. Journal of Cardiovascular Pharmacology. 32(4). 516–520. 14 indexed citations

10.

Baker, Brian, Paul Dorian, Paul Sandor, et al.. (1997). Electrocardiographic Effects of Fluoxetine and Doxepin in Patients With Major Depressive Disorder. Journal of Clinical Psychopharmacology. 17(1). 15–21. 40 indexed citations

11.

Newman, David, et al.. (1997). Circadian variation of sustained ventricular tachycardia in patients subject to standard adrenergic blockade. American Heart Journal. 134(4). 752–757. 9 indexed citations

12.

Geist, Michael, et al.. (1996). Hyperaldosteronism and sudden cardiac death. The American Journal of Cardiology. 78(5). 605–606. 6 indexed citations

13.

Naccarelli, Gerald V., Paul Dorian, Stefan H. Hohnloser, & P Coumel. (1996). Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The American Journal of Cardiology. 77(3). 53A–59A. 93 indexed citations

14.

Dorian, Paul, et al.. (1994). Importance of ST-segment depression as a determinant of ventricular premature complex frequency after thrombolysis for acute myocardial infarction. The American Journal of Cardiology. 74(5). 419–423. 2 indexed citations

15.

Dorian, Paul, et al.. (1993). Sotalol and type IA drugs in combination prevent recurrent of sustained ventricular tachycardia. Journal of the American College of Cardiology. 22(1). 106–113. 11 indexed citations

16.

Newman, David, Paul Dorian, & Randi Feder-Elituv. (1993). Isoproterenol antagonizes drug-induced prolongation of action potential duration in humans. Canadian Journal of Physiology and Pharmacology. 71(10-11). 755–760. 14 indexed citations

17.

Dorian, Paul & David Newman. (1993). Effect of sotalol on ventricular fibrillation and defibrillation in humans. The American Journal of Cardiology. 72(4). A72–A79. 61 indexed citations

18.

Newman, David, Paul Dorian, Eugene Downar, et al.. (1992). Use of telemetry functions in the assessment of implanted antitachycardia device efficacy. The American Journal of Cardiology. 70(6). 616–621. 10 indexed citations

19.

Langer, Anatoly, Paul Dorian, Luigi Casella, et al.. (1992). Pathophysiology and prognostic significance of holter-detected ST segment depression after myocardial infarction. Journal of the American College of Cardiology. 20(6). 1313–1317. 38 indexed citations

20.

Lee, John Tayu, Yin‐Gail Yee, Paul Dorian, & Robert E. Kates. (1987). Influence of Hepatic Dysfunction on the Pharmacokinetics of Propafenone. The Journal of Clinical Pharmacology. 27(5). 384–389. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact